Drug supply agreements with accession option
Arnzeimittelverträge mit Beitrittsoption
Germany · Wuppertal · how to bid here →
Your path to submission
- Deadline: 1 May 2027 at 12:00 — 206 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU, DEU, DEU.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (81 awards, most recently August 2026) — the next award is due around October 2026 by that rhythm. The last award went to BG Hexal 1 A Pharma GbR.n = 81
- The median procedure drew 6 bids (277 procedures with a bid count); 17% ended with a single bidder. Sector: median 2 bids.n = 277
- 50% of this buyer's awards went to companies that had already won here before (279 awards since 2024, spread over 134 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 279 awards since 2024
- < 1% of the bids received came from other countries (149 procedures with a bid mix) — all bidders, not just the winners. Sector: 5%.n = 149
- From notice to award takes a median 137 days here (89 procedures). Sector: 90 days.n = 89
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 06/10/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 265 contracts went to foreign companies over the last 3 years (of 22,200 recorded awards) — mostly from Austria, Netherlands, France.
Submission language: DEU.
Typical field: median 11 (from 81 awards).
What the buyer is looking for
This notice does not concern the award of a public contract within the meaning of the Procurement Coordination Directive (2014/24/EU) or antitrust procurement law. This notice is published in the Supplement to the Official Journal of the European Union in order to provide interested pharmaceutical companies with the widest possible information. The procedural name "open procedure" (point IV.1.1) used in the context of this notice text is due to the requirements of the notice form. This and the use of the medium "TED" do not imply any submission to procurement regulations, the validity of which is not obligatory by law or procurement regulations. It is a framework contract with an accession option covering various active substances. · The subject of the contract are medicinal products containing the active substance(s)/combination of active substances referred to in the title.
Selection criteria — not structured in the notice
The buyer left the criteria block of the EU form empty; the eligibility requirements are in the tender documents. The document analysis below extracts them from there — bid and evidence in German.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| AMAROX PHARMA GmbH · Haar | 6 | 2025–2026 |
| Zentiva Pharma GmbH · Frankfurt am Main | 6 | 2025–2026 |
| Basics GmbH · Leverkusen | 5 | 2026 |
| Werbeartikel Muesch e.K. · Troisdorf | 5 | 2024–2025 |
| T-Systems International GmbH · Düsseldorf | 5 | 2024–2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.